Global Women’s Health Market – Industry Analysis, Segments, Key Players and Trends to 2026

Women's Health Information & Referral Services

Updated on Aug 28, 2019

View more like this | Visit United States Minor Outlying Islands, UN | Contact Million Insights Inc.
Image for Global Women’s Health Market – Industry Analysis, Segments, Key Players and Trends to 2026 with ID of: 3714563

The global women’s health market size is expected to reach USD 54.6 billion by 2026, according to a new report by Radiant Insights, Inc., expanding at a CAGR of 4.2% over the forecast period. Government and various private organizations are focused on women health across the globe, which is likely to drive the market in the coming years. Coverage provided to women is one of the key factors expected to drive the market in developed countries.



In the U.S., coverage plans provide preventive services for women without any copayment charges. This includes anemia screening on a routine basis, folic acid supplements for women who may become pregnant, hepatitis B screening, breast cancer screening, contraception, and many others. Healthy People 2020 was established by the Department of Health and Human Services to improve the health of all Americans in 10 years.



Download Free Sample Report @ https://www.radiantinsights.com/research/womens-health-market/request-sample



Initiatives by countries from the Asia Pacific region, such as India, China, Japan, Australia, and Singapore, are likely to boost the market over the forecast period. For instance, in September 2016, Ministry of Health, Australia, announced funding of AUD 5.6 million (around USD 3.8 million) until 2019 to Jean Hailes, a women’s health organization to help expand its education and outreach.

With aging and increasing incidence of obesity, the prevalence of OA is anticipated to grow.



According to the United Nations, about 10% to 15% of all adults aged over 60 have some degree of OA, and the condition is more prevalent in women. According to the CDC, in 2013, back problems were more common in women (30.2%). According to the International Osteoporosis Foundation (IOF), the worldwide prevalence of osteoporosis among women was over 200.0 million in 1990, which is anticipated to reach 680.0 million in 2050.



Further Key Findings From the Study Suggest:

• Based on application, the women’s health market is segmented into postmenopausal osteoporosis, infertility, endometriosis, contraceptives, menopause, and Polycystic Ovary Syndrome (PCOS). Of these, postmenopausal osteoporosis held a majority of the market share in terms of revenue in 2018.

• Availability of a wide range of drugs for the treatment of postmenopausal osteoporosis is projected to boost the market. These include Fosamax, Actonel, Boniva, Reclast, Evista, and Prolia. In April 2017, the U.S. FDA approved a new drug, Tymlos, to treat postmenopausal osteoporosis. The approval was based on data of 18-month trial that demonstrated a substantial reduction in the risk of vertebral & nonvertebral fractures.

• North America held the largest market share in 2018 in terms of revenue pertaining to the technological advancements and presence of major market players in the region. Asia Pacific, on the other hand, is expected to showcase the fastest growth rate over the forecast period.

• Some of the key players in the market are Bayer AG; Allergan; Merck & Co., Inc.; Teva Pharmaceuticals; Pfizer; Agile Therapeutics; Amgen, Inc.; AstraZeneca, Bristol-Myers Squibb, Ferring B.V.



Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/womens-health-market



Table of Contents



Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Application
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective - 1
1.8.2 Objective - 2



Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Application
2.2.2 Region
2.3 Competitive Insights



Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Penetration & Growth Prospect Mapping
3.2.1 Penetration Analysis
3.2.2 Market Driver Analysis
3.2.2.1 Rising Incidence Of Target Disorders
3.2.2.2 Child Or Early Marriages
3.2.2.3 Initiatives By Government And Various Organizations
3.2.3 Market Restraint Analysis
3.2.3.1 Patent expiry of major drugs
3.2.3.2 Lawsuits related to contraceptives
3.3 Women’s Health Market: Business Environment Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 Pestel Analysis
3.4 Clinical Pipeline Analysis
3.5 Approval of Few Drugs in Recent Years



Chapter 4 Women’s Health Market: Drug Analysis
4.1 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Drug Segment
4.1.1 EVISTA
4.1.1.1 Evista market, 2015 - 2026 (USD Million)
4.1.2 XGEVA
4.1.2.1 Xgeva market, 2015 - 2026 (USD Million)
4.1.3 PROLIA
4.1.3.1 Prolia market, 2015 - 2026 (USD Million)
4.1.4 MIRENA
4.1.4.1 Mirena market, 2015 - 2026 (USD Million)
4.1.5 ZOMETA
4.1.5.1 Zometa market, 2015 - 2026 (USD Million)
4.1.6 RECLAST/ACLASTA
4.1.6.1 Reclast/Aclasta market, 2015 - 2026 (USD Million)
4.1.7 MINASTRIN 24FE
4.1.7.1 Minastrin 24FE market, 2015 - 2026 (USD Million)
4.1.8 NUVARING
4.1.8.1 NuvaRing market, 2015 - 2026 (USD Million)
4.1.9 FORTEO
4.1.9.1 Forteo market, 2015 - 2026 (USD Million)
4.1.10 PREMARIN
4.1.10.1 Premarin market, 2015 - 2026 (USD Million)
4.1.11 ACTONEL
4.1.11.1 Actonel market, 2015 - 2026 (USD Million)
4.1.12 ORTHO-TRI-CY LO 28
4.1.12.1 Ortho-Tri-Cy LO 28 market, 2015 - 2026 (USD Million)



Chapter 5 Women’s Health Market: Application Analysis
5.1 Women’s Health Application Market Share Analysis, 2018 & 2026
5.2 Women’s Health Application Market: Segment Dashboard:
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
5.3.1 Postmenopausal Osteoporosis
5.3.1.1 Postmenopausal Osteoporosis Market, 2015 - 2026 (USD Million)
5.3.2 Hormonal Infertility
5.3.2.1 Hormonal Infertility Market, 2015 - 2026 (USD Million)
5.3.3 Endometriosis
5.3.3.1 Endometriosis Market, 2015 - 2026 (USD Million)
5.3.4 Contraceptives
5.3.4.1 Contraceptives Market, 2015 - 2026 (USD Million)
5.3.5 Menopause
5.3.5.1 Menopause Market, 2015 - 2026 (USD Million)
5.3.6 Polycystic Ovary Syndrome (Pcos)
5.3.6.1 Pcos Market, 2015 - 2026 (USD Million)



Read all Reports of this category @ https://www.radiantinsights.com/catalog/healthcare



About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assists and facilitate organizations and individuals procure market research reports, helping them in the decisions making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.



















































































Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Phone: (415) 349-0054
Toll Free: 1-888-928-9744
Address: 201 Spear Street 1100, Suite 3036,
City: San Francisco; State: California; Country: United States
Email: [email protected]
Website: https://www.radiantinsights.com/
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.